YaleABNLab (@YaleABNLab) header
YaleABNLab (@YaleABNLab) profile picture

Official Twitter for Dr. Anahita Bassir Nia's Adversity, Brain, Novel Therapeutics (ABN) Laboratory.

New Haven, CT
Joined August 2024
Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)Photo by YaleABNLab (@YaleABNLab)
Excited to spotlight the work of our lab at the American Academy of Addiction Psychiatry (AAAP) 37th Annual Meeting! Tomorrow, members of the ABN Lab will be presenting two posters showcasing our research and contributions to advancing the field of addiction psychiatry.
2
37
Had such a great time at my first @CPDDorg ✨ This chapter is over, but the journey continues. Excited to keep exploring what drives cannabis use and how these motivations shape people’s experiences. @YalePsych @YaleABNLab @anahitabassir #CPDD2026#cannabisuse
3
6
170
Why people with psychosis use cannabis more than general population? My amazing postdoc, @YaldaFarahmand, presented our study trying to answer this question at #CPDD2026. @YaleABNLab – at West Haven, CT
I’m honored to present our study on cannabis motivations at the @CPDDorg this year! I’d be excited to meet everyone at the poster sessions tomorrow! @YalePsych @YaleABNLab @anahitabassir #cannabismotivation#YalePsychiatry#CPDD2026
2
3
155
MEAI is a non-hallucinergic psychedelic with chemical structure similar to MDMA. In this review from our lab, we discussed the potential Therapeutic use if MEAI in the treatment of alcohol use disorder (AUD). #psychedelics #MDMA #MEAI @YaleABNLab @YalePsych – at West Haven, CT
1
1
147
We will discuss findings and lessons learned from our ongoing first-in-human clinical trial of MEAI in healthy participants and individuals with alcohol use disorder. @YaleABNLab @YalePsych – at West Haven, CT
2
3
112
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,650. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!
1
1
7
332
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,675. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324
1
34
Excited to receive #ACNP senior researcher travel award! Looking forward to a wonderful meeting #acnp2026 in #Bahamas (Jan 2026)! @YalePsych @YaleABNLab @ACNPorg
We're excited to showcase another group of the stellar @ACNPorg Travel Awardees who will be joining us for #ACNP2026 🤩 See below for more about them, their research, and other fun facts 👇
2
8
1,050
Dr. Anahita Bassir Nia focuses on translational research on the neurobiology of stress-related disorders and addiction, with a main focus on cannabinoids and psychedelics 🍄💊 / @anahitabassir
1
2
6
702
Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!
3
76
Yale ABNLab will be presenting at @SOBP 2025 in Toronto this week! Please see below for more details! #Neuroscience #NeuroPsych #PsychResearch #2025SOBP
3
2
6
1,607
Read our latest #research on the contribution of #psychotherapy to #psychedelic treatment for #opioid #addiction, published with @SpringerNature in Current Addiction Reports. Read here: rdcu.be/eaAo9
1
1
125
Hey @acnp. I am Anahita, an assistant professor @YalePsych. I study the #endocannabinoid system and #psychedelics in #addiction and #ptsd. @YaleABNLab. Looking forward to the next three days! #acnp2024
1
24